FORT WORTH, Texas—VERTESS, a health care mergers and acquisitions (M&A) advisory firm, announced the closing of five major health care transactions in Quarter 3 (Q3) 2023 with a combined total transaction value of $75 million. The five transactions were in various health care verticals. The headwinds faced earlier in the year due to global and domestic economic pressures are clearing and signs for a profitable Q4 and 2024 are strong, VERTESS said.
"At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity," said Bradley Smith, the managing director for one of the sellers. "We continued to push forward and remain patient. We are pleased for our clients that our perseverance with buyers resulted in several successes."
The health care verticals for the five closed transactions included Pediatric-focused Home Medical Equipment and Service Providers, Home Health Care Services, Custom Rehab and Durable Medical Equipment as well as Retail Pharmacy. More than half of the VERTESS managing directors successfully closed deals in Q3.
"We are encouraged by the uptick in deal activity at the end of 2023," said VERTESS Managing Partner Vaughne Glennie. "Although the dry powder remained available for many buyers, there was clearly some risk avoidance starting in mid-2022. As we continue to launch new deals this fall, the heightened response we've received from buyers clearly shows a trend toward a very active 2024 in health care M&A. Our managing directors are always available to talk to health care business owners about their future goals and to be a resource for any exit planning."
For more information, contact Vaughne Glennie at 367547@email4pr.com or (202) 302-1621.
